⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3310184 | 1.00 | — | — | |
| SCHEMBL3899974 | 1.00 | — | — | |
| SCHEMBL3136461 | 0.86 | MEN1 (0.38) | — | |
| SCHEMBL3127579 | 0.86 | MEN1 (0.38) | — | |
| SCHEMBL14524980 | 0.81 | — | — | |
| SCHEMBL14348202 | 0.81 | — | — | |
| SCHEMBL5277725 | 0.77 | — | — | |
| SCHEMBL23927965 | 0.74 | — | — | |
| SCHEMBL16581458 | 0.74 | MEN1 (0.36) | — | |
| SCHEMBL18922081 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773740-B1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | UNIV SYDNEY (AU) | 2009-02-18 | — | — | EP | disclosed |
| US-20080032950-A1 | Neurologically-Active Compounds | THE UNIVERSITY OF SYDNEY (AU) | 2008-02-07 | — | — | US | disclosed |
| US-20080032950-A1 | Neurologically-Active Compounds | THE UNIVERSITY OF SYDNEY (AU) | 2008-02-07 | — | — | US | disclosed |
| US-20080032950-A1 | Neurologically-Active Compounds | THE UNIVERSITY OF SYDNEY (AU) | 2008-02-07 | — | — | US | disclosed |
| EP-1773740-A4 | NEUROLOGICALLY-ACTIVE COMPOUNDS | UNIV SYDNEY (AU) | 2007-09-19 | — | — | EP | disclosed |
| EP-1773740-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006000043-A1 | NEUROLOGICALLY-ACTIVE COMPOUNDS | THE UNIVERSITY OF SYDNEY (AU) | 2006-01-05 | — | — | WO | disclosed |